Back to News
Market Impact: 0.35
Insmed Incorporated Reports Third-Quarter 2026 Revenues of $524.4 Million
Source: Nasdaq
Corporate EarningsCompany FundamentalsHealthcare & Biotech
Insmed reported third-quarter 2026 revenue of $524.4 million for the period ended September 30. BRINSUPRI generated $400.1 million, up 29% from the second quarter of 2026; the provided article text does not include comparisons with expectations or further results.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.35
Ticker Sentiment
INSM0.70
More News
- Insmed Reports Third-Quarter 2026 Financial Results and Provides Business Update
- DoorDash offers $17 billion for Instacart: ‘the largest companies are only eating more and more of the pie’
- Alphabet Erases $500 Billion as ChatGPT, Google AI Cut into Search
- Alphabet just had its worst day as a public company. BofA now values Google search at a lower multiple than fossil fuel stocks
- Alphabet’s stock has worst day in over 20 years, dragging the S&P 500 to first loss in four days
- Warren urges DOJ criminal probe of Bank of America over anti-money-laundering violations